Suppr超能文献

2009 年 Ras/MAPK 通路遗传综合征会议记录:从床边到实验室再回到床边。

Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.

机构信息

University of California San Francisco, San Francisco, California, USA.

出版信息

Am J Med Genet A. 2010 Jan;152A(1):4-24. doi: 10.1002/ajmg.a.33183.

Abstract

The RASopathies are a group of genetic syndromes caused by germline mutations in genes that encode components of the Ras/mitogen-activated protein kinase (MAPK) pathway. Some of these syndromes are neurofibromatosis type 1, Noonan syndrome, Costello syndrome, cardio-facio-cutaneous syndrome, LEOPARD syndrome and Legius syndrome. Their common underlying pathogenetic mechanism brings about significant overlap in phenotypic features and includes craniofacial dysmorphology, cardiac, cutaneous, musculoskeletal, GI and ocular abnormalities, and a predisposition to cancer. The proceedings from the symposium "Genetic Syndromes of the Ras/MAPK Pathway: From Bedside to Bench and Back" chronicle the timely and typical research symposium which brought together clinicians, basic scientists, physician-scientists, advocate leaders, trainees, students and individuals with Ras syndromes and their families. The goals, to discuss basic science and clinical issues, to set forth a solid framework for future research, to direct translational applications towards therapy and to set forth best practices for individuals with RASopathies were successfully meet with a commitment to begin to move towards clinical trials.

摘要

RAS 相关疾病是一组由 Ras/丝裂原活化蛋白激酶(MAPK)通路相关基因的胚系突变引起的遗传综合征。这些综合征包括神经纤维瘤病 1 型、Noonan 综合征、Costello 综合征、心面四肢综合征、LEOPARD 综合征和 Legius 综合征。它们共同的潜在发病机制导致了表型特征的显著重叠,包括颅面畸形、心脏、皮肤、肌肉骨骼、胃肠道和眼部异常,以及癌症易感性。本次研讨会的会议记录“Ras/MAPK 通路的遗传综合征:从床边到实验室再到临床”,记录了一次及时而典型的研究研讨会,汇集了临床医生、基础科学家、医师科学家、倡导领袖、受训者、学生和 Ras 综合征患者及其家属。会议的目标是讨论基础科学和临床问题,为未来的研究奠定坚实的框架,将转化应用指向治疗,并为 RAS 相关疾病患者制定最佳实践。会议成功地达到了这些目标,并承诺开始进行临床试验。

相似文献

1
Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.
Am J Med Genet A. 2010 Jan;152A(1):4-24. doi: 10.1002/ajmg.a.33183.
2
Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.
Am J Med Genet A. 2015 Jan;167A(1):1-10. doi: 10.1002/ajmg.a.36793. Epub 2014 Nov 12.
3
Proceedings of the fifth international RASopathies symposium: When development and cancer intersect.
Am J Med Genet A. 2018 Dec;176(12):2924-2929. doi: 10.1002/ajmg.a.40632. Epub 2018 Oct 10.
4
The RASopathies.
Annu Rev Genomics Hum Genet. 2013;14:355-69. doi: 10.1146/annurev-genom-091212-153523. Epub 2013 Jul 15.
5
First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
Am J Med Genet A. 2019 Jun;179(6):1091-1097. doi: 10.1002/ajmg.a.61125. Epub 2019 Mar 25.
6
A review of craniofacial and dental findings of the RASopathies.
Orthod Craniofac Res. 2017 Jun;20 Suppl 1(Suppl 1):32-38. doi: 10.1111/ocr.12144.
7
Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
Expert Rev Mol Med. 2008 Dec 9;10:e37. doi: 10.1017/S1462399408000902.
8
Rasopathies - dysmorphic syndromes with short stature and risk of malignancy.
Endocr Regul. 2013 Oct;47(4):217-22. doi: 10.4149/endo_2013_04_217.
9
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
Hum Mutat. 2008 Aug;29(8):992-1006. doi: 10.1002/humu.20748.
10
RASopathies: The musculoskeletal consequences and their etiology and pathogenesis.
Bone. 2021 Nov;152:116060. doi: 10.1016/j.bone.2021.116060. Epub 2021 Jun 16.

引用本文的文献

2
Non-Mammalian Models for Understanding Neurological Defects in RASopathies.
Biomedicines. 2024 Apr 10;12(4):841. doi: 10.3390/biomedicines12040841.
4
Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
Heart. 2022 Oct 28;108(22):1807-1814. doi: 10.1136/heartjnl-2021-320729.
5
Patient engagement in the design of clinical research in Noonan syndrome spectrum disorders: a scoping review.
Orphanet J Rare Dis. 2021 Oct 26;16(1):449. doi: 10.1186/s13023-021-02083-x.
6
Clinical Insights Into Heritable Cardiomyopathies.
Front Genet. 2021 Apr 28;12:663450. doi: 10.3389/fgene.2021.663450. eCollection 2021.
7
Adult pilocytic astrocytoma in the molecular era: a comprehensive review.
CNS Oncol. 2021 Mar 1;10(1):CNS68. doi: 10.2217/cns-2020-0027. Epub 2021 Jan 15.
8
deletion results in depletion of the transcription factor and a specific loss of parvalbumin cortical interneurons.
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6189-6195. doi: 10.1073/pnas.1915458117. Epub 2020 Mar 2.
9
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
Am J Med Genet A. 2020 Apr;182(4):866-876. doi: 10.1002/ajmg.a.61485. Epub 2020 Jan 8.
10
Functional divergence caused by mutations in an energetic hotspot in ERK2.
Proc Natl Acad Sci U S A. 2019 Jul 30;116(31):15514-15523. doi: 10.1073/pnas.1905015116. Epub 2019 Jul 11.

本文引用的文献

1
The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
Curr Opin Genet Dev. 2009 Jun;19(3):230-6. doi: 10.1016/j.gde.2009.04.001. Epub 2009 May 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验